These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

288 related articles for article (PubMed ID: 1060115)

  • 1. Brain receptors for antipsychotic drugs and dopamine: direct binding assays.
    Seeman P; Chau-Wong M; Tedesco J; Wong K
    Proc Natl Acad Sci U S A; 1975 Nov; 72(11):4376-80. PubMed ID: 1060115
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antipsychotic drug doses and neuroleptic/dopamine receptors.
    Seeman P; Lee T; Chau-Wong M; Wong K
    Nature; 1976 Jun; 261(5562):717-9. PubMed ID: 945467
    [No Abstract]   [Full Text] [Related]  

  • 3. Antipsychotic drugs: direct correlation between clinical potency and presynaptic action on dopamine neurons.
    Seeman P; Lee T
    Science; 1975 Jun; 188(4194):1217-9. PubMed ID: 1145194
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dopamine receptors in human and calf brains, using [3H]apomorphine and an antipsychotic drug.
    Seeman P; Chau-Wong M; Tedesco J; Wong K
    Proc Natl Acad Sci U S A; 1976 Dec; 73(12):4354-8. PubMed ID: 12505
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of specificity and stereoselectivity of rat brain dopamine receptors.
    Miller JC; Friedhoff AJ
    Int J Dev Neurosci; 1986; 4(1):21-6. PubMed ID: 2458672
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sigma opiates and certain antipsychotic drugs mutually inhibit (+)-[3H] SKF 10,047 and [3H]haloperidol binding in guinea pig brain membranes.
    Tam SW; Cook L
    Proc Natl Acad Sci U S A; 1984 Sep; 81(17):5618-21. PubMed ID: 6147851
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dopamine receptor binding predicts clinical and pharmacological potencies of antischizophrenic drugs.
    Creese I; Burt DR; Snyder SH
    Science; 1976 Apr; 192(4238):481-3. PubMed ID: 3854
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Binding of [3H]pergolide mesylate to dopamine receptors of mammalian brains.
    Wong DT; Bymaster FP; Lane PT; Kau D; Bach NJ; Kornfeld EC
    Res Commun Chem Pathol Pharmacol; 1980 Nov; 30(2):195-210. PubMed ID: 7444158
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antischizophrenic drugs: chronic treatment elevates dopamine receptor binding in brain.
    Burt DR; Creese I; Snyder SH
    Science; 1977 Apr; 196(4287):326-8. PubMed ID: 847477
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 3H-dopamine uptake and 3H-haloperidol binding in striatum after administration of methyl mercury to rats.
    Komulainen H; Tuomisto J
    Arch Toxicol; 1985 Sep; 57(4):268-71. PubMed ID: 3004382
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of some derivatives of 2-aminotetralin on dopamine-sensitive adenylate cyclase and on the binding of (3H)haloperidol to neuroleptic receptors in the rat striatum.
    Cannon JG; Costall B; Laduron PM; Leysen JE; Naylor RJ
    Biochem Pharmacol; 1978 May; 27(10):1417-20. PubMed ID: 567987
    [No Abstract]   [Full Text] [Related]  

  • 12. Elevation of brain neuroleptic/dopamine receptors in schizophrenia.
    Lee T; Seeman P
    Am J Psychiatry; 1980 Feb; 137(2):191-7. PubMed ID: 6101525
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serotonergic component of neuroleptic receptors.
    Leysen JE; Niemegeers CJ; Tollenaere JP; Laduron PM
    Nature; 1978 Mar; 272(5649):168-71. PubMed ID: 564466
    [No Abstract]   [Full Text] [Related]  

  • 14. 3H-Haloperidol binding to dopamine receptors in rat corpus striatum: influence of chlorpromazine metabolites and derivatives.
    Creese I; Manian AA; Prosser TD; Snyder SH
    Eur J Pharmacol; 1978 Feb; 47(3):291-6. PubMed ID: 631182
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification and distribution of neuroleptic binding sites in the rat spinal cord.
    Demenge P; Mouchet P; Guerin B; Feuerstein C
    J Neurochem; 1981 Jul; 37(1):53-9. PubMed ID: 6114137
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dopamine receptor binding: differentiation of agonist and antagonist states with 3H-dopamine and 3H-haloperidol.
    Creese I; Burt DR; Snyder SH
    Life Sci; 1975 Sep; 17(6):933-1001. PubMed ID: 1195989
    [No Abstract]   [Full Text] [Related]  

  • 17. The demonstration in vivo of specific binding sites for neuroleptic drugs in mouse brain.
    Höllt V; Czlonkowski A; Herz A
    Brain Res; 1977 Jul; 130(1):176-83. PubMed ID: 560239
    [No Abstract]   [Full Text] [Related]  

  • 18. Blockade of apomorphine's discriminative stimulus properties: relation to neuroleptic activity in neuropharmacological and biochemical assays.
    Colpaert FC; Leysen JE; Niemegeers CJ; Janssen PA
    Pharmacol Biochem Behav; 1976 Dec; 5(6):671-9. PubMed ID: 1035804
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Striatal synaptosomal tyrosine hydroxylase activity. A model system for study of presynaptic dopamine receptors.
    McMillen BA
    Biochem Pharmacol; 1982 Aug; 31(16):2643-7. PubMed ID: 6128002
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stereospecific binding of 3H-haloperidol in rat dorsal spinal cord.
    Demenge P; Feuerstein C; Mouchet P; Guerin B
    Eur J Pharmacol; 1980 Aug; 66(1):117-20. PubMed ID: 7408959
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.